SCOTT MARSTELLER: Open Payments
NPI 1891714937 · BROOKVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 70 payments from 20 companies in 2025. Trend: 2023 $760 · 2024 $899 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $257 |
| Novo Nordisk Inc | 6 | $108 |
| Amgen Inc. | 7 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Neurocrine BioSciences, Inc. | 3 | $74 |
| PFIZER INC. | 3 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Lilly USA, LLC | 3 | $47 |
Products named: VRAYLAR, CAPLYTA, OTEZLA, TRINTELLIX, INGREZZA, Ozempic, QULIPTA, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
